Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000507216 | SCV000602120 | likely pathogenic | not provided | 2017-05-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023422 | SCV000742431 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-02-16 | criteria provided, single submitter | clinical testing | The c.309delC pathogenic mutation, located in coding exon 5 of the PTEN gene, results from a deletion of one nucleotide at nucleotide position 309, causing a translational frameshift with a predicted alternate stop codon (p.C105Vfs*8). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Mayo Clinic Laboratories, |
RCV000507216 | SCV000692008 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV002275045 | SCV002562841 | likely pathogenic | Seizure | no assertion criteria provided | clinical testing |